Cytek Biosciences, Inc.CTKBNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
2.14
↑ 106% above average
Average (5y)
-33.60
Historical baseline
Range
High:5.39
Low:-155.66
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 2.14 | -31.8% |
| 2023 | 3.14 | -2.8% |
| 2022 | 3.23 | -40.1% |
| 2021 | 5.39 | +103.5% |
| 2020 | -155.66 | -160.2% |
| 2019 | -59.83 | - |